Digital NeuroPort Biopotential Signal Processing System— 510(k) K202174
Substantially EquivalentBlackrock Microsystems
FDA 510(k) clearance K202174 for Digital NeuroPort Biopotential Signal Processing System, Substantially Equivalent on 2021-02-10. Applicant: Blackrock Microsystems.
Clearance details
- Applicant
- Blackrock Microsystems
- Product code
- Code GWL
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Salt Lake City, UT, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.